Millions of Americans are living with – and fighting against – Type 2 diabetes. While some medications help consumers control symptoms and curb medical issues, pioglitazone-based treatments such as Actos, Actoplus Met, and Duetact may do more harm than good when consumed past a certain point.
Recent medical research has found that beyond 12 months, pioglitazone patients face a markedly increased probability of developing bladder cancer as a result of their Actos treatment. Some researchers estimate the increased risk to be as high as 40 percent.
In response to this medical phenomenon, thousands of patients have taken legal action, filing a medical product liability suit against the maker of this powerful and potentially harmful medication. In fact, claimants may reach as high as 10,000 litigants, according to some experts in this field.
The law firm of Nachawati Law Group has the experience, understanding, and dedication necessary to help you and your family if you’ve experienced a pioglitazone-related adverse outcome. Find out what you need to know about your potential for filing a claim by talking to our professionals today. For a free consultation, call us at 1.866.545.8364 or email . We’re ready to give you the help you need.
———
About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact or call 214-890-0711.
